Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The frequency depends on the type of peptide
Weeks 21 to 24: 2.5 mg every other week
The medication must be prepared according to medical guidelines, and administered immediately after preparation to ensure stability
Retatrutide Retatrutide is designed as a once-weekly injectable triple hormone receptor agonist that activates the receptors for: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) Glucagon This triple-receptor action aims to improve appetite regulation, glucose control, and energy expenditure potentially leading to greater metabolic effects than earlier drugs targeting only one or two pathways
I test claims against research and user experiences
US$ 20.80
US$ 23.72
US$ 22.06
US$ 28.63
